Mitchell McLeod Pugh & Williams’s Amgen AMGN Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$954K	Buy	2,634 +682	+35%	+$233K	0.12%	146
2026 Q1	$687K	Buy	1,952 +20	+1%	+$7.13K	0.1%	167
2025 Q4	$743K	Sell	1,932 -1	-0.1%	-$317	0.11%	157
2025 Q3	$565K	Sell	1,933 -537	-22%	-$156K	0.09%	170
2025 Q2	$690K	Buy	2,470 +109	+5%	+$30.9K	0.13%	150
2025 Q1	$736K	Buy	2,361 +78	+3%	+$23K	0.15%	138
2024 Q4	$595K	Sell	2,283 -472	-17%	-$140K	0.12%	152
2024 Q3	$888K	Hold	2,755	–	–	0.19%	120
2024 Q2	$861K	Hold	2,755	–	–	0.2%	115
2024 Q1	$783K	Buy	2,755 +331	+14%	+$96.9K	0.19%	126
2023 Q4	$698K	Buy	2,424 +176	+8%	+$48K	0.18%	129
2023 Q3	$604K	Buy	2,248 +147	+7%	+$36.7K	0.18%	131
2023 Q2	$467K	Sell	2,101 -13	-0.6%	-$3.02K	0.13%	155
2023 Q1	$511K	Sell	2,114 -13	-0.6%	-$3.19K	0.16%	146
2022 Q4	$559K	Sell	2,127 -4	-0.2%	-$1.07K	0.19%	132
2022 Q3	$480K	Buy	2,131 +30	+1%	+$7.27K	0.18%	131
2022 Q2	$511K	Buy	2,101 +13	+0.6%	+$3.19K	0.2%	128
2022 Q1	$505K	Sell	2,088 -14	-0.7%	-$3.22K	0.17%	142
2021 Q4	$473K	Sell	2,102 -2,136	-50%	-$451K	0.16%	149
2021 Q3	$901K	Hold	4,238	–	–	0.33%	90
2021 Q2	$1.03M	Hold	4,238	–	–	0.4%	72
2021 Q1	$1.05M	Sell	4,238 -6	-0.1%	-$1.43K	0.44%	67
2020 Q4	$976K	Hold	4,244	–	–	0.45%	68
2020 Q3	$1.08M	Hold	4,244	–	–	0.55%	56
2020 Q2	$1M	Sell	4,244 -712	-14%	-$162K	0.57%	54
2020 Q1	$1M	Hold	4,956	–	–	0.78%	36
2019 Q4	$1.2M	Hold	4,956	–	–	0.75%	40
2019 Q3	$959K	Hold	4,956	–	–	0.65%	50
2019 Q2	$913K	Sell	4,956 -200	-4%	-$35.8K	0.63%	52
2019 Q1	$980K	Sell	5,156 -11	-0.2%	-$2.1K	0.68%	46
2018 Q4	$1.01M	Hold	5,167	–	–	0.81%	35
2018 Q3	$1.07M	Buy	5,167 +11	+0.2%	+$2.17K	0.72%	37
2018 Q2	$952K	Hold	5,156	–	–	0.67%	43
2018 Q1	$879K	Sell	5,156 -54	-1%	-$9.91K	0.63%	51
2017 Q4	$906K	Buy	5,210 +54	+1%	+$9.56K	0.63%	50
2017 Q3	$961K	Hold	5,156	–	–	0.71%	44
2017 Q2	$888K	Buy	5,156 +2,848	+123%	+$463K	0.67%	51
2017 Q1	$379K	Sell	2,308 -110	-5%	-$18.3K	0.3%	123
2016 Q4	$354K	Buy	2,418 +323	+15%	+$48.6K	0.29%	125
2016 Q3	$349K	Sell	2,095 -150	-7%	-$25.4K	0.31%	115
2016 Q2	$342K	Hold	2,245	–	–	0.31%	110
2016 Q1	$337K	Sell	2,245 -700	-24%	-$104K	0.33%	105
2015 Q4	$478K	Hold	2,945	–	–	0.48%	78
2015 Q3	$407K	Hold	2,945	–	–	0.42%	85
2015 Q2	$452K	Buy	2,945 +200	+7%	+$32K	0.42%	88
2015 Q1	$439K	Buy	2,745 +150	+6%	+$23.6K	0.4%	89
2014 Q4	$413K	Buy	+2,595	New	+$404K	0.38%	96

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's AMGN Position: Q2 2026 in Review

Mitchell McLeod Pugh & Williams increased its Amgen (AMGN) stake by 35% in Q2 2026, buying an estimated $233K and bringing the position to 2,634 shares worth $954K. The position accounts for 0.12% of the portfolio, ranked #146.

Mitchell McLeod Pugh & Williams first reported a position in AMGN in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.2M in Q4 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Mitchell McLeod Pugh & Williams held 2,634 shares of Amgen worth $954K as of Q2 2026.
Mitchell McLeod Pugh & Williams bought 682 Amgen shares in Q2 2026, an estimated $233K.
Amgen made up 0.12% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #146 holding.
Mitchell McLeod Pugh & Williams first reported a position in Amgen in Q4 2014 and has held it in 47 quarters since.
Mitchell McLeod Pugh & Williams's Amgen position peaked at $1.2M in Q4 2019.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.